Synonyms:
Status: Phase 3
Entry Type: Antibody

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interferon beta inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Myositis 3 D009220 ClinicalTrials
Lupus Erythematosus, Cutaneous 2 D008178 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297808